DI
NXTM

DUMAC Inc’s NxStage Medical Inc. NXTM Stock Holding History

DUMAC Inc’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-70,000
Closed -$1.74M – 34
2018
Q1 		$1.74M Buy
70,000
+20,000
+40% +$486K 2.38% 10
2017
Q4 		$1.21M Buy
50,000
+19,700
+65% +$519K 1.16% 16
2017
Q3 		$836K Buy
+30,300
New +$808K 0.88% 17

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

DUMAC Inc's NXTM Position: Q2 2018 in Review

DUMAC Inc sold out of NxStage Medical Inc. (NXTM) in Q2 2018, closing a stake of 70,000 shares — an estimated $1.74M sold.

DUMAC Inc first reported a position in NXTM in Q3 2017 and held it in 3 quarters. The position peaked at $1.74M in Q1 2018. 171 funds tracked by Wall St. Rank hold NXTM as of Q2 2018.

  • DUMAC Inc reported no remaining NxStage Medical Inc. position as of Q2 2018 after selling out during the quarter.
  • DUMAC Inc sold 70,000 NxStage Medical Inc. shares in Q2 2018, an estimated $1.74M.
  • DUMAC Inc first reported a position in NxStage Medical Inc. in Q3 2017 and held it in 3 quarters.
  • DUMAC Inc's NxStage Medical Inc. position peaked at $1.74M in Q1 2018.
  • 171 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q2 2018.

Based on DUMAC Inc's 13F filing for Q2 2018, filed 14 Aug 2018.